16 / 54
Interim Report 2015
二零一五年中期報告
15
Disclosure of Directors’ and Chief Executive’s Interests
(Continued)
董事及行政總裁的權益披露
（續）
previously exercised). The subscription amount payable in respect of each
share option upon exercise of an option shall be determined by the Board
and shall be not less than the greater of:
(i) the closing price of the shares on the SEHK’s daily quotation sheet
on the date, which must be a business day, of a written offer of such
option (the “Date of Grant”);
(ii) the average closing price of the shares on the SEHK as stated in the
SEHK’s daily quotation sheets for the five business days immediately
preceding the Date of Grant; and
(iii) the nominal value of the shares.
At its meetings on 19 March 2007 and 14 April 2008 respectively, the Board
approved an allotment of share options under the Post-IPO Share Option Scheme
to all permanent staff. The terms are the same as those stated in (b) above.
Starting from 2009, the foregoing Share Option Schemes were discontinued
and replaced by the above-mentioned Share Award Scheme. However, share
options previously awarded under these Share Option Schemes remain valid,
subject to the same terms and conditions.
Share Option Scheme 2014
The Company adopted a new share option scheme on 9 May 2014 (the “Share
Option Scheme 2014”) whereby the Directors of the Company are authorised
to invite employees of the Group, including its Directors of any company in the
Group, to take up options to subscribe for shares in the Company at a nominal
consideration of HK$1.00 per grant under the Share Option Scheme 2014.
Each option gives the holder the right to subscribe for one ordinary share in the
Company.
The purpose of the Share Option Scheme 2014 is:
(a) to assist the Company to attract and retain the best available personnel;
and
(b) to provide additional incentives to employees, directors, consultants,
business associates and advisers to promote the success of the Group;
by providing them with an opportunity to have a personal stake in the Company
through an offer of grant of options. The Shares subject to the Share Option
Scheme 2014 will be identical in nature with the other Shares of the Company.
The total number of share options which may be issued upon exercise of all
options to be granted under the Share Option Scheme 2014 shall not exceed in
aggregate 10% of the issued capital of the Company at its adoption date, being
9 May 2014 (the “Scheme Mandate Limit”). Options that have lapsed shall
not be counted for the purpose of calculating the Scheme Mandate Limit. The
Scheme Mandate Limit may be renewed by obtaining approval of shareholders
in general meetings of the Company provided that such total number of shares
which may be issued upon exercise of all options to be granted under the
Share Option Scheme 2014 under the Scheme Mandate Limit as renewed
shall not exceed 10% of the shares issued at the date of approval of such limit
(the “Refreshed Limit”). Options previously granted (including those outstanding,
cancelled, lapsed or exercised) shall not be counted for the purpose of
calculating the Refreshed Limit.
購股權所涉及的股份數目）。因行使購股權而須就每份
購股權支付的認購款項，將由董事會釐定，且不得低
於下列各項中的最高者：
(i)
於購股權的書面要約日期（「授出日期」，其必須為
營業日），於香港聯交所每日報價表所列股份的收
市價；
(ii)
緊貼授出日期前五個營業日，於香港聯交所每日
報價表所列股份在香港聯交所的平均收市價；及
(iii)
股份面值。
於二零零七年三月十九日及二零零八年四月十四日舉行的董
事會會議上，董事會批准根據首次公開招股後購股權計劃向
所有長期僱員配發購股權，有關條款與上文
(b)
項中所述者相
同。
自二零零九年起，前述購股權計劃已予終止，並由上述股份
獎勵計劃所取代。然而，先前根據該等購股權計劃授出的購
股權仍然有效，並受相同條款及條件規限。
二零一四年購股權計劃
本公司於二零一四年五月九日採納新購股權計劃（「二零一四
年購股權計劃」），據此，本公司董事獲授權邀請本集團僱員
（包括本集團旗下任何公司的董事）接納可認購本公司股份的
購股權。有關購股權乃根據二零一四年購股權計劃以每份
港幣
1.00
元的象徵式代價授出。每份購股權賦予持有人權
利，可認購本公司一股普通股。
二零一四年購股權計劃之目的如下：
(a)
協助本公司吸引及保留最佳員工；及
(b)
為僱員、董事、專業顧問、業務夥伴及諮詢顧問提供
額外獎勵，以促進本集團成功；
此計劃將透過授出購股權為合資格人士提供以個人身份持有
本公司權益的機會。二零一四年購股權計劃所涉股份在本質
上與本公司其他股份相同。
根據二零一四年購股權計劃將予授出的所有購股權予以行
使時可予發行的股份總數，合共不得超過本公司於採納日
期（即二零一四年五月九日）的已發行股本
10%
（「計劃授權限
額」）。在計算計劃授權限額時，已失效的購股權不得計算在
內。計劃授權限額可於本公司股東大會上取得股東批准後更
新，惟按更新後的計劃授權限額，根據二零一四年購股權
計劃將予授出的所有購股權予以行使時可予發行的股份總
數，不得超過批准該限額當日已發行股份的
10%
（「經更新限
額」）。就計算經更新限額而言，以往授出的購股權（包括尚
未行使、已註銷、失效或行使者）不得計算在內。